Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORE LITHIUM LTD Director's Dealing 2019

Nov 28, 2019

64737_rns_2019-11-28_5d02fb0d-92f9-42b5-8a8a-10cb2c2de5bf.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Core Lithium Ltd
ABN 80 146 287 809

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director StephenBIGGINS
Date of last notice 2 August 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. 1. Mr Biggins is a director of and hasabeneficialinterestintheregisteredholderNowakInvestments Pty Ltd ATF TheNowakSuperannuationFund
(Nowak)
2. Mr Biggins is a director of and hasabeneficialinterestinthe
registered holder Genex ResourcesPty Ltd ATF Biggins ResourcesFamily Trust (Genex)
Date of change 29 November 2019
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to s held prior to change 5,9 79,680 Shar666 Sh es held by Nohld b G wak
2,2 ,7 ar s e y en x
2,000,000 unlisted Performance Rightssubject to vesting criteria, expiring atvarious times to 30 September 2020 heldby Genex
Class Shares - Fully paid ordinary shares.PerformanceRights–subjecttosatisfaction of performance conditions.Options - unquoted options with anexercise price of 6.0 cents each and expiryof 30 June 2023.
Number acquired 5,000,000 Options13,000,000 Performance Rights
Number disposed Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation Nil
No. of securities held after change 5,979,680 Shares held by Nowak2,216,667 Shares held by Genex15,000,000 unlisted Performance Rightssubject to vesting criteria, expiring atvarious times to 30 June 2026 held byGenex5,000,000 Options held by Genex
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back Issue of director remuneration optionsand performance rights as approved byshareholders at the 2019 AGM.
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Not applicable
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation
Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? Not applicable
If so, was prior written clearance provided to allow the tradeto proceed during this period?
If prior written clearance was provided, on what date was thisprovided?
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3